Andere Sprachen electroCore, Inc.

Aktien

A3D3BQ

US28531P2020

ECOR

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
5.76 ^USD	+1.95%		+1.95%	-3.22%

08.04.	ElectroCore, Inc. kündigt die Markteinführung von Truvaga Plus® für allgemeines Wohlbefinden an	CI
13.03.	ElectroCore, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ElectroCore Announces the Launch of Truvaga Plus® for General Wellness	08.04.
ElectroCore, Inc. Announces the Launch of Truvaga Plus® for General Wellness	08.04.
ElectroCore Expands Intellectual Property Portfolio	02.04.
ElectroCore, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13.03.
ElectroCore, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13.03.
Earnings Flash (ECOR) ELECTROCORE Posts Q4 Revenue $5.2M, vs. Street Est of $5M	13.03.
ElectroCore Announces Fourth Quarter and Full Year 2023 Financial Results	13.03.
ElectroCore to Participate in Upcoming Investor Conferences	12.03.
ElectroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024	05.03.
ElectroCore Expands Intellectual Property Portfolio	06.02.
Certain Common Stock of electroCore, Inc. are subject to a Lock-Up Agreement Ending on 28-JAN-2024.	28.01.
Certain Warrants of electroCore, Inc. are subject to a Lock-Up Agreement Ending on 28-JAN-2024.	28.01.
Certain Options of electroCore, Inc. are subject to a Lock-Up Agreement Ending on 28-JAN-2024.	28.01.
Ondine Biomedical appoints Joseph Errico as new CFO	16.01.
ElectroCore Expands Intellectual Property Portfolio	09.01.
ElectroCore Says Two US Patents Issued for Non-Invasive Vagus Nerve Stimulation Technology	26.12.
ElectroCore Expands Intellectual Property Portfolio	26.12.
ElectroCore, Inc. Appoints Charles S. Theofilos as New Class Iii Member of the Board	14.12.
ElectroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology	12.12.
Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023	15.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen electroCore, Inc.

Aktien

A3D3BQ

US28531P2020

ECOR

Andere Sprachen

Filter